scPharmaceuticals (SCPH) - 2020 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K SCPHARMACEUTICALS INC. (Exact name of registrant as specified in its Charter) Delaware 46-5184075 (State or other jurisdiction of incorporation or organization) 2400 District Avenue, Suite 310 Burlington, Massachusetts 01803 (Address of principal executive offices) (Zip Code) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSI ...